Alpha 2.0
Login Register
» Authors » Takamitsu Inoue

Takamitsu Inoue

Explore the profile of Takamitsu Inoue including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 180
Citations 1231
Followers 0
Related Specialties
Oncology
Urology
General Surgery
Top 10 Co-Authors
Tomonori Habuchi
Mitsuru Saito
Shigeru Satoh
Shintaro Narita
Norihiko Tsuchiya
Kazuyuki Numakura
Hiroshi Tsuruta
Yohei Horikawa
Teruaki Kumazawa
Taketoshi Nara
Published In
Hinyokika Kiyo
Int J Clin Oncol
Jpn J Clin Oncol
Urology
Clin Exp Nephrol
Affiliations
Soon will be listed here.
Recent Articles
1.
Successful treatment with low-dose oral steroids for contracted bladder after intravesical instillation of Bacillus Calmette-Guérin
Katami A, Inoue T, Sakurai H, Onozawa M, Hisasue S, Kawai K, et al.
IJU Case Rep . 2024 Mar; 7(2):185-187. PMID: 38440709
Introduction: Contracted bladder is a rare adverse effect of intravesical Bacillus Calmette-Guérin instillation, with an incidence of 0.2-3.3%. This report aimed to present a case of contracted bladder successfully treated...
2.
Influence of genetic polymorphisms in vascular endothelial-related genes on the clinical outcome of axitinib in patients with metastatic renal cell carcinoma
Numakura K, Igarashi R, Takahashi M, Nara T, Kanda S, Saito M, et al.
Cancer Biol Ther . 2024 Feb; 25(1):2312602. PMID: 38327067
Objective: Axitinib is an oral multi-target tyrosine kinase inhibitor used for the treatment of renal cell carcinoma (RCC). Because of the severe adverse events (AEs) associated with axitinib, patients often...
3.
Correction to: Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022
Yanagita M, Muto S, Nishiyama H, Ando Y, Hirata S, Doi K, et al.
Clin Exp Nephrol . 2023 Dec; 28(2):123-124. PMID: 38070021
No abstract available.
4.
The Japanese Urological Association's clinical practice guidelines for urotrauma 2023
Horiguchi A, Shinchi M, Ojima K, Iijima K, Inoue K, Inoue T, et al.
Int J Urol . 2023 Nov; 31(2):98-110. PMID: 37929795
The Japanese Urological Association's guidelines for the treatment of renal trauma were published in 2016. In conjunction with its revision, herein, we present the new guidelines for overall urotrauma. Its...
5.
Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022
Yanagita M, Muto S, Nishiyama H, Ando Y, Hirata S, Doi K, et al.
Clin Exp Nephrol . 2023 Oct; 28(2):85-122. PMID: 37878114
No abstract available.
6.
Chapter 2:indications and dosing of anticancer drug therapy in patients with impaired kidney function, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022
Nishiyama H, Inoue T, Koizumi Y, Kobayashi Y, Kitamura H, Yamamoto K, et al.
Int J Clin Oncol . 2023 Aug; 28(10):1298-1314. PMID: 37572198
This comprehensive review discusses the dosing strategies of cancer treatment drugs for patients with impaired kidney function, specifically those with chronic kidney disease (CKD), undergoing hemodialysis, and kidney transplant recipients....
7.
[A Case of Germ Cell Tumor in which Necrotic Tissue Revealed hCG-Positive in Surgical Specimen of Post-Chemotherapy Retroperitoneal Lymph Node Dissection]
Sakurai H, Kawai K, Onozawa M, Inoue T, Miyazaki J
Hinyokika Kiyo . 2023 Jul; 69(6):157-162. PMID: 37460279
The patient was a 27-year-old male. In December 2020, he was diagnosed with a primary extragonadal germ cell tumor of the retroperitoneum with inferior vena caval (IVC) involvement. After 3...
8.
Chapter 1: Evaluation of kidney function in patients undergoing anticancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022
Muto S, Matsubara T, Inoue T, Kitamura H, Yamamoto K, Ishii T, et al.
Int J Clin Oncol . 2023 Jun; 28(10):1259-1297. PMID: 37382749
The prevalence of CKD may be higher in patients with cancer than in those without due to the addition of cancer-specific risk factors to those already present for CKD. In...
9.
Author Reply
Inoue T
Urology . 2022 Dec; 173:229-230. PMID: 36586425
No abstract available.
10.
Are we ready for building transition programs for heart transplant recipients in Japan? - Knowing the unique background is the first step for discussion
Kato T, Gomi H, Aizawa Y, Kawamura A, Eisen H, Hunt S, et al.
Front Pediatr . 2022 Nov; 10:935167. PMID: 36405837
No abstract available.